Acumen Pharmaceuticals, Inc.
ABOS
$2.97
-$0.20-6.17%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.18% | 9.87% | -7.70% | -11.69% | -3.87% |
| Total Receivables | 15.09% | 9.47% | 38.30% | 27.76% | -20.51% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -63.43% | -94.15% | 751.78% | 315.98% | -64.86% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 20.80% | -14.08% | -8.00% | -4.21% | -6.66% |
| Total Current Assets | -13.21% | 8.87% | -7.49% | -10.95% | -4.22% |
|
|
|||||
| Total Current Assets | -13.21% | 8.87% | -7.49% | -10.95% | -4.22% |
| Net Property, Plant & Equipment | -22.84% | -18.93% | -15.63% | -14.03% | -10.19% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 0.00% | -17.24% | -3.33% | -40.00% | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.27% | -64.72% | 38.20% | 107.07% | -14.33% |
| Total Assets | -13.19% | 8.79% | -13.63% | -17.26% | -15.93% |
|
|
|||||
| Total Accounts Payable | 708.40% | 198.74% | -18.77% | -67.57% | 99.15% |
| Total Accrued Expenses | 5.54% | -68.72% | 138.95% | -23.50% | 26.84% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 38.72% | 59.70% | 138.11% | 2,536.62% | 2.90% |
| Total Finance Division Other Current Liabilities | -66.20% | 176.11% | -48.86% | 118.63% | -61.48% |
| Total Other Current Liabilities | -66.20% | 176.11% | -48.86% | 118.63% | -61.48% |
| Total Current Liabilities | 60.28% | -2.59% | 36.67% | -11.68% | 28.71% |
|
|
|||||
| Total Current Liabilities | 60.28% | -2.59% | 36.67% | -11.68% | 28.71% |
| Long-Term Debt | -29.71% | -24.43% | -17.21% | -9.47% | 1.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -49.35% | -32.46% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.28% | -11.93% | 6.84% | -10.53% | 11.98% |
|
|
|||||
| Common Stock & APIC | 0.46% | 7.32% | 0.47% | 0.48% | 0.49% |
| Retained Earnings | -7.00% | -4.64% | -5.97% | -6.70% | -11.57% |
| Treasury Stock & Other | -161.90% | -74.70% | -23.85% | 373.91% | 53.33% |
| Total Common Equity | -34.54% | 24.20% | -24.41% | -20.42% | -24.72% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -34.54% | 24.20% | -24.41% | -20.42% | -24.72% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -34.54% | 24.20% | -24.41% | -20.42% | -24.72% |
|
|
|||||